Suchergebnisse - "Cazzola, M."

PubPharm (685)

1

Prolonged-release pirfenidone in patients with pulmonary fibrosis as a phenotype of post-acute sequelae of COVID-19 pneumonia. Safety and efficacy

enthalten in: Respiratory medicine | 2023

von Sansores, R. | Ramírez-Venegas, A. | Montiel-Lopez, F. | +11

2

Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement

in: International Journal of COPD | 2023

von Manzetti GM | Ora J | Sepiacci A | +3

3

The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset

in: International Journal of COPD | 2022

von Calverley PMA | Papi A | Page C | +5

4

The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset [Corrigendum]

in: International Journal of COPD | 2022

von Calverley PMA | Papi A | Page C | +5

5

Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile

in: Journal of Asthma and Allergy | 2022

von Rogliani P | Cavalli F | Chetta A | +2

6

Beyond Dual Bronchodilation – Triple Therapy, When and Why

in: International Journal of COPD | 2022

von Cazzola M | Rogliani P | Laitano R | +2

7

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS

enthalten in: Leukemia | 2021

von Kuendgen, A. | Nomdedeu, M. | Tuechler, H. | +47

8

An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease

in: Biologics: Targets & Therapy | 2021

von Cazzola M | Ora J | Cavalli F | +2

9

New Avenues for Phosphodiesterase Inhibitors in Asthma

in: Journal of Experimental Pharmacology | 2021

von Matera MG | Ora J | Cavalli F | +2

10

Brensocatib. Dipeptidyl peptidase 1 (DPP1) inhibitor, Treatment of non-cystic fibrosis bronchiectasis

enthalten in: Drugs of the future | 2021

von Cazzola, M. | Matera, M. | Rogliani, P. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[69]